No. 6 seed Ole Miss apparently dodged a major injury Saturday against No. 11 seed Tulane in the first round of the College Football Playoff, as Rebels coach Pete Golding told reporters after the 41-10 victory that running back Kewan Lacy has a “bruised shoulder” and will be further evaluated over the weekend.
Pete Golding said RB Kewan Lacy has a bruised shoulder and will be further evaluated.
Lacy rushed for 89 yards on 15 carries – including a 20-yard touchdown run in the first quarter – against No. 11 seed Tulane in the CFP first round Saturday at Vaught-Hemingway Stadium before sustaining the injury late in the second quarter. He was able to return to the field after the break, but exited again in the second half.
Lacy, who transferred from Missouri to Ole Miss after his 2024 season, has gained 1,279 yards on 258 carries with 20 touchdowns in 13 games so far in 2025. He also has 25 receptions for 154 yards.
Ole Miss advances to take on No. 3 seed Georgia in the Sugar Bowl on New Year’s Day (8 pm ET, ESPN), the first time either SEC power has played each other in the postseason.
Georgia owns a 34-14-1 record all time against Ole Miss dating back to 1940, and the teams have played 5 neutral-site games – all in the regular season – against each other throughout history.
Pete Golding gives injury update on running back Kewan Lacy Saturday Down South.
Hence then, the article about pete golding gives injury update on running back kewan lacy was published today ( ) and is available on SATURDAY DOWN SOUTH ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Pete Golding gives injury update on running back Kewan Lacy )
Also on site :
- Javier Bardem, Mark Ruffalo, Walter Salles, Isabel Coixet, Annemarie Jacir & Yorgos Lanthimos Sign Anti-Bolloré Letter As Signatures Swell To 3.5K
- 2026 ASCO Abstract Highlights: Innovent Biologics' IBI363 (PD-1/IL-2α-bias bispecific fusion protein) Demonstrates Robust Survival Benefits in Long-Term Follow-up of PoC Study in Advanced Immunotherapy-Resistant Non-Small Cell Lung Cancer
- Man’s belly button next to Trump during Oval Office announcement steals the show on social media